Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Gastrointestinal 1

Conditions

Breast Neoplasms 3Neoplasms 2Motor Activity 2Lymphoma 2Anxiety Disorders 2Weight Gain 1Vomiting 1Triple Negative Breast Neoplasms 1Treatment Adherence and Compliance 1Recurrence 1Obesity 1Nausea 1Lymphoma, Large B-Cell, Diffuse 1Lymphedema 1Gastrointestinal Neoplasms 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

Cyclophosphamide 444Rituximab 401Etoposide 224Vincristine 215Doxorubicin 201Filgrastim 200Prednisone 176Cytarabine 159Radiotherapy 152fludarabine phosphate 147Methotrexate 137Peripheral Blood Stem Cell Transplantation 129Melphalan 127fludarabine 115Busulfan 99Dexamethasone 93Tacrolimus 75Carmustine 74Granulocyte Colony-Stimulating Factor 73Mycophenolic Acid 71Gemcitabine 66Bortezomib 65Antilymphocyte Serum 65Whole-Body Irradiation 62Cyclosporine 62Bendamustine Hydrochloride 62Lenalidomide 60Ifosfamide 58sargramostim 51Methylprednisolone 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Lymphoma × Weights and Measures × Clear all
NCT03530969 2024-02-20

Geriatric Communication Skills Training Program for Oncology Clinicians

Memorial Sloan Kettering Cancer Center

Phase NA Completed
88 enrolled
GastrointestinalLymphoid

Gastrointestinal Neoplasms, Lymphoma

NCT03260855 2023-08-23

PResEnCE

University Hospital, Toulouse

Phase NA Completed
200 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡